Морфологические предикторы эффективности терапии митотаном при адренокортикальном раке

BACKGROUND: Adrenocortical cancer (ACC) is an orphan malignant tumor of the adrenal cortex with a predominantly poor prognosis and an aggressive clinical course. Nowadays, mitotane is a non-alternative drug in the treatment of ACC. The search for prognostic parameters that determine the sensitivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Ткачук, А. В., Бельцевич, Д. Г., Порубаева, Э. Э., Урусова, Л. С.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrinology Research Centre 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939962/
https://www.ncbi.nlm.nih.gov/pubmed/36689714
http://dx.doi.org/10.14341/probl13172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939962/
https://www.ncbi.nlm.nih.gov/pubmed/36689714
http://dx.doi.org/10.14341/probl13172

Ejemplares similares